|
x |
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
|
o |
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Delaware
|
|
06-0853042
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer Identification Number)
|
3
Great Pasture Road
|
|
06813
|
|
Danbury,
Connecticut
(Address
of Principal Executive Offices)
|
Zip
Code
|
|
Page
|
|||
PART
I. FINANCIAL INFORMATION
|
|
|||
Item
1.
|
|
Consolidated
Financial Statements (unaudited)
|
||
|
|
Consolidated
Balance Sheets as of January 31, 2008 and October 31, 2007
|
3
|
|
|
|
Consolidated
Statements of Operations for the three months ended January 31, 2008
and
2007
|
4
|
|
Consolidated
Statements of Cash Flows for the three months ended January 31, 2008
and
2007
|
5
|
|||
|
|
Notes
to Consolidated Financial Statements
|
6
|
|
|
||||
Item
2.
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
|
16
|
|
|
||||
Item
3.
|
|
Quantitative
and Qualitative Disclosures about Market Risk
|
27
|
|
|
||||
Item
4.
|
|
Controls
and Procedures
|
28
|
|
|
||||
PART
II. OTHER INFORMATION
|
|
|||
|
||||
Item 6.
|
|
Exhibits
|
29
|
|
|
|
Signature
|
30
|
January
31,
2008
|
October
31,
2007
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
81,865
|
$
|
92,997
|
|||
Investments:
U.S. treasury securities
|
54,635
|
60,634
|
|||||
Accounts
receivable, net of allowance for doubtful accounts of $37 and $63,
respectively
|
10,402
|
10,063
|
|||||
Inventories,
net
|
35,411
|
29,581
|
|||||
Other
current assets
|
7,513
|
7,730
|
|||||
Total
current assets
|
189,826
|
201,005
|
|||||
Property,
plant and equipment, net
|
38,761
|
39,612
|
|||||
Investments:
U.S. treasury securities
|
2,079
|
-
|
|||||
Investment
and loan to affiliate
|
11,792
|
12,216
|
|||||
Other
assets, net
|
404
|
355
|
|||||
Total
assets
|
$
|
242,862
|
$
|
253,188
|
|||
|
|||||||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Current
portion of long-term debt and other liabilities
|
$
|
849
|
$
|
924
|
|||
Accounts
payable
|
9,746
|
9,516
|
|||||
Accounts
payable due to affiliate
|
1,372
|
2,881
|
|||||
Accrued
liabilities
|
9,471
|
8,511
|
|||||
Deferred
license fee income
|
600
|
-
|
|||||
Deferred
revenue and customer deposits
|
27,139
|
20,486
|
|||||
Total
current liabilities
|
49,177
|
42,318
|
|||||
Long-term
deferred revenue
|
3,948
|
4,401
|
|||||
Long-term
debt and other liabilities
|
579
|
613
|
|||||
Total
liabilities
|
53,704
|
47,332
|
|||||
Redeemable
minority interest
|
12,322
|
11,884
|
|||||
Redeemable
preferred stock ($0.01 par value, liquidation preference of $64,120
at
January 31, 2008 and October 31, 2007.)
|
59,950
|
59,950
|
|||||
Shareholders’
equity:
|
|||||||
Common
stock ($.0001 par value); 150,000,000 shares authorized at January
31,
2008 and October 31, 2007; 68,291,750 and 68,085,059 shares issued
and
outstanding at January 31, 2008 and October 31, 2007,
respectively.
|
7
|
7
|
|||||
Additional
paid-in capital
|
573,725
|
571,944
|
|||||
Accumulated
deficit
|
(456,846
|
)
|
(437,929
|
)
|
|||
Treasury
stock, Common, at cost (12,282 shares at January 31, 2008 and October
31,
2007)
|
(126
|
)
|
(126
|
)
|
|||
Deferred
compensation
|
126
|
126
|
|||||
Total
shareholders’ equity
|
116,886
|
134,022
|
|||||
Total
liabilities and shareholders’ equity
|
$
|
242,862
|
$
|
253,188
|
Three
Months Ended
January
31,
|
|||||||
Revenues:
|
2008
|
2007
|
|||||
Product
sales and revenues
|
$
|
9,768
|
$
|
4,899
|
|||
Research
and development contracts
|
5,251
|
1,935
|
|||||
Total
revenues
|
15,019
|
6,834
|
|||||
Costs
and expenses:
|
|||||||
Cost
of product sales and revenues
|
19,410
|
13,382
|
|||||
Cost
of research and development contracts
|
4,440
|
1,944
|
|||||
Administrative
and selling expenses
|
4,812
|
4,417
|
|||||
Research
and development expenses
|
5,484
|
6,855
|
|||||
Total
costs and expenses
|
34,147
|
26,598
|
|||||
Loss
from operations
|
(19,128
|
)
|
(19,764
|
)
|
|||
License
fee income, net
|
—
|
34
|
|||||
Interest
expense
|
(32
|
)
|
(27
|
)
|
|||
Loss
from equity investments
|
(443
|
)
|
(217
|
)
|
|||
Interest
and other income, net
|
1,125
|
1,129
|
|||||
Loss
before redeemable minority interest
|
(18,479
|
)
|
(18,845
|
)
|
|||
Redeemable
minority interest
|
(438
|
)
|
(391
|
)
|
|||
Loss
before provision for income taxes
|
(18,917
|
)
|
(19,236
|
)
|
|||
Provision
for income taxes
|
—
|
—
|
|||||
Net
loss
|
(18,917
|
)
|
(19,236
|
)
|
|||
|
|||||||
Preferred
stock dividends
|
(802
|
)
|
(802
|
)
|
|||
Net
loss to common shareholders
|
$
|
(19,719
|
)
|
$
|
(20,038
|
)
|
|
Loss
per share basic and diluted:
|
|||||||
Net
loss per share to common shareholders
|
$
|
(0.29
|
)
|
$
|
(0.38
|
)
|
|
Basic
and diluted weighted average shares outstanding
|
68,204,735
|
53,172,189
|
Three
Months Ended
January
31,
|
|||||||
2008
|
2007
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(18,917
|
)
|
$
|
(19,236
|
)
|
|
Adjustments
to reconcile net loss to net cash used in
|
|||||||
operating
activities:
|
|||||||
Stock-based
compensation
|
1,254
|
1,302
|
|||||
Loss
in equity investments
|
443
|
217
|
|||||
Loss
on redeemable minority interest
|
438
|
391
|
|||||
Interest
receivable on loan to affiliate
|
(43
|
)
|
—
|
||||
Impairment
of long-lived assets
|
179
|
—
|
|||||
Gain
on derivative
|
(45
|
)
|
(4
|
)
|
|||
Depreciation
|
2,173
|
2,445
|
|||||
Amortization
(accretion) of bond premium (discount)
|
—
|
(306
|
)
|
||||
Provision
for doubtful accounts
|
(26
|
)
|
72
|
||||
(Increase)
decrease in operating assets:
|
|||||||
Accounts
receivable
|
(313
|
)
|
1,373
|
||||
Inventories
|
(5,830
|
)
|
(2,840
|
)
|
|||
Other
assets
|
(184
|
)
|
(1,220
|
)
|
|||
Increase
(decrease) in operating liabilities:
|
|||||||
Accounts
payable
|
(1,279
|
)
|
(4,326
|
)
|
|||
Accrued
liabilities
|
1,108
|
2,723
|
|||||
Deferred
revenue and customer deposits
|
6,200
|
(871
|
)
|
||||
Deferred
license fee income and other
|
600
|
(38
|
)
|
||||
Net
cash used in operating activities
|
(14,242
|
)
|
(20,318
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures
|
(1,467
|
)
|
(1,623
|
)
|
|||
Treasury
notes matured
|
17,100
|
34,000
|
|||||
Treasury
notes purchased
|
(13,180
|
)
|
(19,896
|
)
|
|||
Net
cash provided by investing activities
|
2,453
|
12,481
|
|||||
Cash
flows from financing activities:
|
|||||||
Repayment
of debt
|
(122
|
)
|
(98
|
)
|
|||
Proceeds
from debt
|
—
|
165
|
|||||
Payment
of preferred dividends
|
(802
|
)
|
(802
|
)
|
|||
Net
proceeds from sale of common stock
|
837
|
107
|
|||||
Common
stock issued for option plans
|
744
|
7
|
|||||
Net
cash provided by (used in) financing activities
|
657
|
(621
|
)
|
||||
Net
decrease in cash and cash equivalents
|
(11,132
|
)
|
(8,458
|
)
|
|||
Cash
and cash equivalents-beginning of period
|
92,997
|
26,247
|
|||||
Cash
and cash equivalents-end of period
|
$
|
81,865
|
$
|
17,789
|
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
(Losses)
|
Fair
Value
|
|||||||||
At
January 31, 2008
|
|
|
|
|
|||||||||
U.S.
government obligations
|
$
|
56,714
|
$
|
342
|
$
|
—
|
$
|
57,056
|
|||||
At
October 31, 2007
|
|||||||||||||
U.S.
government obligations
|
$
|
60,634
|
$
|
71
|
$
|
(1
|
)
|
$
|
60,704
|
Reported as: |
January
31,
|
October
31,
|
|||||
2008
|
2007
|
||||||
Short-term
investments
|
$
|
54,635
|
$
|
60,634
|
|||
Long-term
investments
|
2,079
|
—
|
|||||
Total
|
$
|
56,714
|
$
|
60,634
|
January
31,
|
October
31,
|
||||||
2008
|
2007
|
||||||
Raw
materials
|
$
|
10,361
|
$
|
8,682
|
|||
Work-in-process
|
25,050
|
20,899
|
|||||
Total
|
$
|
35,411
|
$
|
29,581
|
January
31,
2008
|
October
31,
2007
|
Estimated
Useful
Life
|
||||||||
Land
|
$
|
524
|
$
|
524
|
—
|
|||||
Building
and improvements
|
6,517
|
6,454
|
10-26
years
|
|||||||
Machinery,
equipment and software
|
54,503
|
53,449
|
3-8
years
|
|||||||
Furniture
and fixtures
|
2,478
|
2,468
|
10
years
|
|||||||
Equipment
leased to others
|
2,063
|
2,063
|
3
years
|
|||||||
Power
plants for use under power purchase agreements
|
17,743
|
17,743
|
10
years
|
|||||||
Construction
in progress
|
5,204
|
5,009
|
||||||||
89,032
|
87,710
|
|||||||||
Less,
accumulated depreciation and amortization
|
(50,271
|
)
|
(48,098
|
)
|
||||||
Total
|
$
|
38,761
|
$
|
39,612
|
Three
months ended
January
31,
|
|||||||
2008
|
2007
|
||||||
Cost
of product sales and revenues
|
$
|
223
|
$
|
201
|
|||
Cost
of research and development contracts
|
74
|
67
|
|||||
General
and administrative expense
|
711
|
729
|
|||||
Research
and development expense
|
232
|
290
|
|||||
Total
share-based compensation
|
$
|
1,240
|
$
|
1,287
|
Three
months ended
January
31,
|
|||||||
2008
|
2007
|
||||||
Expected
life (in years)
|
6.7
|
6.2
|
|||||
Risk-free
interest rate
|
3.69
|
%
|
4.41
|
%
|
|||
Volatility
|
63.6
|
%
|
60.7
|
%
|
|||
Dividend
yield
|
—
|
—
|
Number
of options
|
Weighted
average
option
price
|
||||||
Outstanding
at October 31, 2007
|
5,325,341
|
$
|
11.11
|
||||
Granted
|
1,023,000
|
8.76
|
|||||
Exercised
|
(278,775
|
)
|
2.61
|
||||
Forfeited/Cancelled
|
(33,275
|
)
|
14.33
|
||||
Outstanding
at January 31, 2008
|
6,036,291
|
$
|
11.10
|
Options
Outstanding
|
Options
Exercisable
|
||||||||||||||||||||||
Range of exercise prices |
Number
outstanding
|
Weighted
average remaining contractual life
|
Weighted
average exercise price
|
Number
exercisable
|
Weighted
average exercise price
|
||||||||||||||||||
$
|
0.28
|
-
|
$
|
5.10
|
106,000
|
1.2
|
$
|
1.63
|
106,000
|
$ |
1.63
|
||||||||||||
|
5.11
|
-
|
|
9.92
|
3,406,392
|
7.4
|
7.65
|
1,083,367
|
|
7.58
|
|||||||||||||
|
9.93
|
-
|
|
14.74
|
1,715,281
|
6.3
|
|
12.11
|
1,109,350
|
|
12.77
|
||||||||||||
|
14.75
|
-
|
|
19.56
|
314,618
|
3.2
|
|
16.84
|
313,368
|
|
16.84
|
||||||||||||
|
19.57
|
-
|
|
24.39
|
237,000
|
3.2
|
23.01
|
237,000
|
|
23.01
|
|||||||||||||
|
24.40
|
-
|
|
29.21
|
27,000
|
3.0
|
|
26.15
|
27,000
|
|
26.15
|
||||||||||||
|
29.22
|
-
|
|
34.03
|
166,000
|
2.9
|
29.91
|
166,000
|
|
29.91
|
|||||||||||||
|
34.04
|
-
|
|
48.49
|
64,000
|
2.7
|
|
38.50
|
64,000
|
|
38.50
|
||||||||||||
6,036,291
|
6.8
|
|
11.09
|
3,106,085
|
|
13.33
|
Number
of
Shares
|
||||
Balance
at October 31, 2007
|
308,270
|
|||
Issued
@ $5.67
|
(25,716
|
)
|
||
Balance
at January 31, 2008
|
282,554
|
Three
months ended
January
31, 2008
|
||||
Expected
life (in years)
|
.5
|
|||
Risk-free
interest rate
|
3.95
|
%
|
||
Volatility
|
70
|
%
|
||
Dividend
yield
|
—
|
Balance
at October 31, 2007
|
$ |
134,022
|
||
Increase
in additional paid-in-capital for stock-based compensation
|
1,254
|
|||
Increase
in additional paid-in-capital for stock issued under employee benefit
plans
|
892
|
|||
Common
stock sales
|
437
|
|||
Series
B preferred dividends
|
(802
|
)
|
||
Net
loss
|
(18,917
|
)
|
||
Balance
at January 31, 2008
|
$
|
116,886
|
Three
months ended
January
31,
|
|||||||
Revenues:
|
2008
|
2007
|
|||||
United
States
|
$
|
9,752
|
$
|
6,644
|
|||
Korea
|
4,727
|
—
|
|||||
Total
|
$
|
14,479
|
$
|
6,644
|
Three
months ended
January
31,
|
|||||||
2008
|
2007
|
||||||
Weighted
average basic common shares
|
68,204,735
|
53,172,189
|
|||||
Effect
of dilutive securities(1)
|
-
|
-
|
|||||
Weighted
average basic common shares adjusted for
diluted calculations
|
68,204,735
|
53,172,189
|
(1)
|
We
computed earnings per share without consideration to potentially
dilutive
instruments because losses incurred would make them antidilutive.
Future
potentially dilutive stock options that were in-the-money at January
31,
2008 and 2007 totaled 1,656,773 and 1,916,963,
respectively. Future potentially dilutive stock options that were
not
in-the-money at January 31, 2008 and 2007 totaled 4,372,718 and
4,099,966,
respectively. We also have future potentially dilutive warrants issued,
which vest and expire over time.
As of January 31, 2008, 37,500 warrants were vested with an exercise
price
of $9.89 and we also had 750,000 unvested warrants.
|
|
Three
Months Ended January
31, |
||||||
Cash paid during the period for: |
2008
|
2007
|
|||||
Interest
|
$
|
32
|
$
|
26
|
Supplemental
disclosure of non-cash investing and financing activities:
|
|||||||
Accrued
sales of common stock(1)
|
$
|
400
|
$
|
528
|
|||
Accrued
Employee Stock Purchase Plan
|
$
|
146
|
$
|
128
|
|||
Impact
on investing activities resulting from the sale of the power plant
used
under a PPA to Sierra Nevada Brewing Co.(2)
|
$
|
—
|
$
|
(3,943
|
)
|
(1)
|
Sales
of common stock confirmed during the prior period and settled in
the
current period.
|
(2) |
In
December 2006, we completed the sale of the 1 MW power plant that
had been
operating under a power purchase agreement to the Sierra Nevada Brewing
Co. The net book value of the asset of approximately $3.9 million,
that
was recorded in property, plant and equipment as of October 31, 2006,
was
recorded in cost of product sales and revenues upon the sale of the
asset.
In addition, this sale resulted in the assumption by the buyer of
certain
of our incentive fund liabilities resulting in a $2.2 million decrease
in
deferred revenue liabilities, which was recorded in cost of product
sales
and revenues.
|
·
|
Ultra-clean
(e.g. virtually zero emissions), quiet
operation
|
·
|
High
fuel efficiency
|
·
|
Reliable,
24/7 baseload power
|
·
|
Ability
to site units locally
|
·
|
Potentially
lower cost power generation
|
·
|
Byproduct
high-temperature heat ideal for cogeneration (combined heat and power)
applications.
|
Three
Months Ended
January
31, 2008
|
Three
Months Ended
January
31, 2007
|
|
||||||||||||||||
Revenues:
|
Revenues
|
Percent of
Revenues
|
Revenues
|
Percent of
Revenues
|
Percentage
Increase
in Revenues |
|||||||||||||
Product
sales and revenues
|
$
|
9,768
|
65
|
%
|
$
|
4,899
|
72
|
%
|
98
|
%
|
||||||||
Research
and development contracts
|
5,251
|
35
|
%
|
1,935
|
28
|
%
|
171
|
%
|
||||||||||
Total
|
$
|
15,019
|
100
|
%
|
$
|
6,834
|
100
|
%
|
120
|
%
|
Three
Months Ended
January
31, 2008
|
Three
Months Ended
January
31, 2007
|
|||||||||||||||||
Cost
of revenues:
|
Cost
of
Revenues
|
Percent of
Cost of
Revenues
|
Cost
of
Revenues
|
Percent of
Cost of
Revenues
|
Percentage
Increase
in Cost of Revenues |
|||||||||||||
Product
sales and revenues
|
$
|
19,410
|
81
|
%
|
$
|
13,382
|
87
|
%
|
45
|
%
|
||||||||
Research
and development contracts
|
4,440
|
19
|
%
|
1,944
|
13
|
%
|
128
|
%
|
||||||||||
Total
|
$
|
23,850
|
100
|
%
|
$
|
15,326
|
100
|
%
|
56
|
%
|
Payments
Due by Period
|
|||||||||||||||||||
Contractual
Obligation:
|
Total
|
Less
than
1
Year
|
1
- 3
Years
|
3
- 5
Years
|
More
than
5
Years
|
||||||||||||||
Capital
and Operating lease commitments
(1)
|
$
|
3,806
|
$
|
889
|
$
|
712
|
$
|
897
|
$
|
1,308
|
|||||||||
Term
loans (principal and interest)
|
758
|
746
|
12
|
—
|
—
|
||||||||||||||
Purchase
commitments(2)
|
48,069
|
48,036
|
33
|
—
|
—
|
||||||||||||||
Series
I Preferred dividends payable
(3)
|
25,454
|
502
|
12,409
|
2,509
|
10,034
|
||||||||||||||
Series
B Preferred dividends payable
(4)
|
6,457
|
3,206
|
3,251
|
—
|
—
|
||||||||||||||
Totals
|
$
|
84,544
|
$
|
53,379
|
$
|
16,417
|
$
|
3,406
|
$
|
11,342
|
(1)
|
Future
minimum lease payments on capital and operating
leases.
|
(2)
|
Purchase
commitments with suppliers for materials supplies, and services incurred
in the normal course of business.
|
(3)
|
Quarterly
dividends of Cdn.$312,500 accrue on the Series 1 preferred shares
(subject
to possible reduction pursuant to the terms of the Series 1 preferred
shares on account of increases in the price of our common stock).
We have
agreed to pay a minimum of Cdn.$500,000 in cash or common stock annually
to Enbridge, Inc., the holder of the Series 1 preferred shares, so
long as
Enbridge holds the shares. Interest accrues on cumulative unpaid
dividends
at a 2.45 percent quarterly rate, compounded quarterly, until payment
thereof. Using an exchange rate of Cdn.$1.0034 to U.S.$1.00 (exchange
rate
on January 31, 2008), cumulative unpaid dividends and accrued interest
of
approximately $7.4 million on the Series 1 preferred shares were
outstanding as of October 31, 2007. For
the purposes of this disclosure, we have assumed an exchange rate
of
Cdn.$1.0034 to U.S.$1.00 (exchange rate on January 31, 2008) and
that the
minimum dividend payments would be made through 2010. In 2010, we
would be
required to pay any unpaid and accrued dividends. Subsequent to 2010,
we
would be required to pay annual dividend amounts totaling Cdn.$1.25
million. We have the option of paying these dividends in stock or
cash.
|
(4)
|
Dividends
on Series B Preferred Stock accrue at an annual rate of 5% paid quarterly.
The obligations schedule assumes we will pay preferred dividends
on these
shares through November 20, 2009, at which time the preferred shares
may
be subject to mandatory conversion at the option of the Company.
|
Exhibit
No.
|
Description
|
|
31.1
|
CEO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.2
|
CFO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
FUELCELL
ENERGY,
INC.
(Registrant)
|
||
March
11, 2008
|
|
/s/ Joseph
G. Mahler
|
Date
|
|
Joseph
G. Mahler
Senior
Vice President, Chief Financial
Officer,
Treasurer and Corporate Secretary
(Principal
Financial Officer and Principal Accounting
Officer)
|
Exhibit
No.
|
Description
|
|
31.1
|
CEO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.2
|
CFO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|